The FDA has received 455+ adverse event reports for compounded semaglutide and 320+ reports for compounded tirzepatide, many involving dosing errors from multi-dose vials
Join today and start your journey
In a more fragile world, where geopolitical instability has the potential to cause knock-on effects for commercial activities, Stevanato Groups highly integrated service offering and global reach can provide greater control and introduce higher levels of efficiency and continuity of supply throughout the supply chain, from sourcing raw materials through to the robust production of patient-friendly autoinjectors and pen injectors that are fully compliant with current regulatory requirements
Shared decision-making helps balance benefits and risks
Your Partner in Long-Term Wellness Whether you're transitioning off prescription GLP-1 medications, or simply looking for a natural appetite modulator, this formula is designed to help sustain balanced eating patterns and metabolic resilience
Eligibility for this program hinges primarily on Body Mass Index (BMI) and associated medical conditions: 1